Mouse Epidermal Keratinocytes -neonatal (MEK-n)

Overview

Mouse Epidermal Keratinocytes -neonatal (MEK-n) is a cell model used for research applications where physiologically relevant identity and donor background support interpretation of experimental readouts. Mouse Keratinocytes derived from Skin (Epidermal) within the Integumentary system.

Epidermal keratinocyte is the predominant cell type in the outermost layer of the skin – the epidermis, which serves as a critical barrier to separate and protect the inside of human body from outside environment and damage from pathogens, heat, UV radiation and water loss. Epidermal keratinocytes originate in the stratum basale, and they undergo gradual differentiation and migrate towards the surface of the epidermis until they reach the stratum corneum, where they form a tight layer of nucleus-free and highly keratinized squamous cells. This layer forms an effective barrier to prevent water loss and the entry of infectious agents. Keratinocytes are also known to produce various growth factors, cytokines, antimicrobial peptides, and complement factors. Therefore, keratinocytes are important for wound healing, inflammation, infection, skin microbiome and immune response.

Key elements and design rationale

• Cell identity: Keratinocytes (Primary Cells)
• Source context: Skin; Epidermal; Integumentary
• Donor background: Age: Neonatal
• Biosafety level: BSL-1 (follow your institution’s biosafety program and local regulations)

Product-specific elements (such as tissue source, donor background, and cell classification) help frame how results should be interpreted across assays and experimental conditions.

Biological background

Cells originating from the Integumentary system are commonly studied to understand tissue-specific physiology, signaling, and responses to perturbations in controlled in vitro settings.

Across primary and specialty cell models, experimental outcomes can be influenced by donor heterogeneity, passage history, confluence, and media composition. For interpretation, it is common to validate key markers or functional phenotypes in the user’s assay context and to document culture variables consistently.

Research relevance and current trends

• Increasing use of primary and specialty cells to improve translational relevance for target biology and phenotypic screening.
• Adoption of 3D culture formats and co-culture systems to better capture tissue microenvironments and cell–cell interactions.
• Integration of functional readouts with single-cell and multi-omics profiling to connect phenotype with molecular state.

Common research applications

• Profile identity markers by flow cytometry or immunostaining in cultured cells
• Quantify functional responses to defined stimuli relevant to the model system
• Compare baseline phenotype across donors/conditions using gene expression profiling
• Model wound-healing–relevant signaling and extracellular matrix interactions
• Screen compounds or genetic perturbations for phenotype modulation using viability or imaging endpoints

Interpretation typically focuses on how a perturbation (e.g., cytokine exposure, metabolic stress, genetic manipulation, or compound treatment) shifts marker profiles or functional readouts relative to an appropriate control matched for donor and culture variables.

Notes for experimental interpretation

• Donor-to-donor heterogeneity can influence baseline phenotype and treatment response; include biological replicates when feasible.
• Passage number, confluence, and media composition can shift gene expression and functional readouts; track and report these variables consistently.
• Contamination control (including routine mycoplasma monitoring) supports reproducibility in downstream assays.
• Use appropriate negative/positive controls for the readout (e.g., unstimulated controls, pathway agonists/antagonists) to contextualize observed changes.

SKU:BHC18500089

Customization & Add-ons: Can't find the cell line you need—or require a custom cell-based solution for your project? We can help you source the best match or support custom cell line services for diverse research needs, including cell line sourcing and selection (species, tissue, and disease model matching), stable cell line engineering (overexpression, knockdown, or knockout via CRISPR/Cas9, shRNA, or sgRNA), reporter gene integration (GFP, RFP, luciferase, and other fluorescent or bioluminescent constructs), genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles), inducible expression systems (Tet-On/Off and other regulatable constructs), drug resistance marker selection (puromycin, G418, hygromycin, and others), custom growth and media optimisation for specific assay requirements, scale-up production for high-throughput screening campaigns, and authentication and QC services (STR profiling, mycoplasma testing, viability assessment). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.